{"id":"chlorisondamine","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Antihypertensive Agents","category":"pharmacology"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Cholinergic Agents","category":"pharmacology"},{"label":"Cholinergic Antagonists","category":"pharmacology"},{"label":"Ganglionic Blockers","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"},{"label":"Nicotinic Antagonists","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"ecolid","offLabel":[],"synonyms":["chlorisondamine","chlorisondamin","chlorisondamine chloride","ecolid","ecolid chloride","hisindamon"],"timeline":[],"approvals":[],"brandName":"Ecolid","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like locks, and Ecolid is a key that fits into those locks. When it binds to the right lock, it can turn on or off certain cellular processes to help treat a disease or condition. This is a simplified way of describing how small molecules like Ecolid work to produce their effects.","oneSentence":"Ecolid works by binding to specific proteins or receptors in the body to produce a therapeutic effect.","technicalDetail":"Ecolid's mechanism of action is likely to involve the modulation of specific biological pathways, potentially through the interaction with enzymes, receptors, or other proteins. Further research is needed to determine the precise molecular targets and mechanisms involved."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/598","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CHLORISONDAMINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:33:18.797031","biosimilars":[],"competitors":[],"genericName":"chlorisondamine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"JD3M24F66I","CHEBI":"CHEBI:135514","INN_ID":"609","UMLSCUI":"C0008211","ChEMBL_ID":"CHEMBL1398654","PUBCHEM_CID":"6244","SNOMEDCT_US":"26992003","SECONDARY_CAS_RN":"7701-62-4","MESH_DESCRIPTOR_UI":"D002714"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":575,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ecolid, also known as Chlorisondamine, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological molecules to produce a therapeutic effect. However, without more information, it is difficult to provide a comprehensive summary of its mechanism of action and safety considerations. Further research is needed to fully understand this compound.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}